Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	57.81	142.47	234.49	299.12	187.36
Short-Term Investments	317.27	215.88	156.05	185.62	118.73
Cash & Cash Equivalents	375.08	358.34	390.54	484.74	306.1
Cash Growth	4.67%	-8.24%	-19.43%	58.36%	47.37%
Other Current Assets	3.14	5.72	1.52	2.6	1.66
Total Current Assets	378.22	364.06	392.06	487.35	307.75
Property, Plant & Equipment	87.59	77.65	72.35	70.64	31.57
Long-Term Investments	34.32	43.28	0	0	0
Goodwill and Intangibles	64.3	64.88	30.82	30.82	30.82
Other Long-Term Assets	1.91	1.95	1.8	2.02	1.98
Total Long-Term Assets	188.12	187.75	104.96	103.48	64.37
Total Assets	566.34	551.81	497.02	590.82	372.12
Accounts Payable	45.79	36.66	19.62	25.47	17.35
Current Debt	2.72	2.51	2.55	7.15	0.96
Total Current Liabilities	48.51	39.17	22.17	32.62	18.31
Long-Term Debt	22.33	20.36	20.05	54.55	46.49
Other Long-Term Liabilities	2.94	2.6	0.08	0.14	0.02
Total Long-Term Liabilities	25.26	22.95	20.13	54.69	46.52
Total Liabilities	73.77	62.12	42.3	87.31	64.82
Total Debt	25.04	22.87	22.6	61.7	47.45
Debt Growth	9.52%	1.17%	-63.37%	30.03%	14.48%
Retained Earnings	-959.37	-713.78	-491.91	-322.84	-183.14
Comprehensive Income	0.32	-0.36	-0.16	-0.04	0.02
Shareholders' Equity	492.57	489.69	454.72	503.52	307.3
Net Cash / Debt	350.04	335.48	367.94	423.05	258.65
Net Cash / Debt Growth	4.34%	-8.82%	-13.03%	63.56%	55.56%
Net Cash Per Share	4.17	4.92	5.82	7.64	5.28
Working Capital	329.72	324.89	369.89	454.73	289.45
Book Value Per Share	5.86	7.19	7.19	9.09	6.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).